fingolimod hydrochloride has been researched along with Degenerative Disc Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, K; Chu, M; Dong, Z; Du, J; Gan, M; Geng, D; Kong, F; Liu, Q; Mao, H; Mao, Y; Ni, L; Tao, H; Wu, X; Yang, H; Zhu, P | 1 |
1 other study(ies) available for fingolimod hydrochloride and Degenerative Disc Disease
| Article | Year |
|---|---|
Inhibition of PP2A ameliorates intervertebral disc degeneration by reducing annulus fibrosus cells apoptosis via p38/MAPK signal pathway.
Topics: Animals; Annulus Fibrosus; Apoptosis; Fingolimod Hydrochloride; Hydrogen Peroxide; Intervertebral Disc Degeneration; Mitogen-Activated Protein Kinase 14; p38 Mitogen-Activated Protein Kinases; Protein Phosphatase 2; Rats; Rats, Sprague-Dawley; Signal Transduction | 2024 |